Background: The prevalence, treatment and outcomes of balloon undilatable chronic total occlu-
CTOs were high pressure balloon inflations (64%), rotational atherectomy (31%), laser (21%), and cutting balloons (15%).
Conclusions: Balloon undilatable CTOs are common and are associated with lower success and higher complication rates.
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| I N TR ODU C TI ON
Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has been rapidly evolving with high success rates currently being achieved at experienced centers [1] [2] [3] [4] [5] [6] . Although failure to cross the occlusion with a guidewire is the most common mechanism of CTO PCI failure, additional technical challenges exist, such as inability to advance a balloon after successful guidewire crossing (balloon uncrossable lesions) [7] [8] [9] , and inability to fully dilate the lesion despite multiple balloon inflations (balloon undilatable lesions) ( Figure 1 ). Adequate preparation in such lesions is critical to avoid suboptimal stent expansion that can result in higher rates of stent thrombosis and in-stent restenosis [10, 11] . In view of continuing advancements in CTO crossing devices and techniques, the prevalence of balloon uncrossable and undilatable lesions is likely to increase. We, therefore, examined a large multicenter US CTO PCI registry to determine the frequency, treatment, and outcomes of balloon undilatable lesions.
| M E TH ODS
We examined the frequency and the baseline clinical, angiographic, and procedural characteristics and outcomes of balloon undilatable lesions in the PROGRESS CTO (Prospective Global Registry for the Study of CTO Intervention, NCT02061436). Data collection on balloon undilatable lesions started in 2015. The study was approved by the institutional review board of each center.
| Definitions
Coronary CTOs were defined as coronary lesions with thrombolysis in myocardial infarction (TIMI) grade 0 flow of at least 3-month duration. Estimation of the duration of occlusion was based on the first onset of angina, prior history of myocardial infarction (MI) in the target vessel territory, or comparison with a prior angiogram.
Balloon undilatable CTOs were defined as lesions that could not be expanded despite multiple balloon inflations with a 1:1 sized balloon at a maximum inflation pressure up to 20 atm after successful guidewire crossing, and balloon advancement within the target lesion. Balloon uncrossable lesions were defined as lesions that could not be crossed by balloon after successful guidewire crossing into the true lumen distal to the occlusion. Balloon inflations >20 atm were defined as high-pressure. Calcification assessment was based on angiography as follows: mild (spots), moderate (involving 50% of the reference lesion diameter) and severe (involving >50% of the reference lesion diameter). Moderate proximal vessel tortuosity was defined as the presence of at least two bends >708 or one bend >908 and severe tortuosity as two bends >908 or one bend >1208 in the CTO vessel. Blunt or no stump was defined as lack of tapering or lack of a funnel shape at the proximal cap. Interventional collaterals were defined as collaterals considered amenable to crossing by a guidewire and a microcatheter by the operator.
Technical success was described as successful CTO revascularization with achievement of <30% residual diameter stenosis within the treated segment and restoration of TIMI grade 3 antegrade flow. Procedural success was defined as achievement of technical success without any in-hospital complications. Inhospital major adverse cardiac events (MACEs) included any of the following adverse events prior to hospital discharge: death, MI, recurrent symptoms requiring urgent repeat target vessel revascularization with PCI or coronary artery bypass graft surgery (CABG), tamponade requiring either pericardiocentesis or surgery, and stroke. Periprocedural MI was defined using the Third Universal Definition of MI (type 4a MI) [12] . Procedure time was calculated from administration of local anesthetic for vascular access to removal of the last catheter. The J-CTO score was calculated as described by Morino et al. [13] , the PROGRESS-CTO score as described by Christopoulos et al. [14] , and the PROGRESS-CTO Complications score as described by Danek et al. [15] .
| Statistical analysis
Categorical variables were described as percentages and were compared using Pearson's chi-square test or Fisher's exact test.
Continuous variables were expressed as mean 6 standard deviation or median [interquartile range, IQR] unless otherwise specified and were compared using the t-test or Wilcoxon rank-sum test, as appropriate. All statistical analyses were performed with JMP 13.0 (SAS Institute, Cary, NC). A two-sided P value of 0.05 was considered statistically significant. US centers. The prevalence of balloon undilatable lesions was 12% (52 of 425). Mean patient age was 65 6 10 years, and most patients were men (84%). Patients with balloon undilatable lesions were more likely to have diabetes mellitus (67 vs. 41%, P < 0.001), congestive heart failure (44 vs. 28%, P 5 0.027), and lower left ventricular ejection fraction (45 6 13 vs. 50 6 13%, P 5 0.015) ( Table 1) . However, the prevalence of prior CABG (45 vs. 35%, P 5 0.175), and dialysis (2 vs. 2%, P 5 1.000) were similar in the two groups.
The angiographic characteristics of the study lesions are presented in Table 2 . The most common CTO target vessel was the right coronary artery (54%), followed by the left anterior descending artery (24%), and left circumflex (21%). As compared with balloon dilatable lesions, balloon undilatable lesions were longer (median length was 40 mm vs. 30 mm [IQR 15-40], P 5 0.016), and more likely to be associated with moderate or severe calcification (87 vs. 54%, P < 0.001).
They also had higher J-CTO score (3.2 6 1.1 vs. 2.5 6 1.3, P < 0.001), and PROGRESS-CTO complications score (3.9 6 1.7 vs. 3.1 6 2.0, 
| Procedural techniques
The techniques used for treating balloon undilatable lesions and the clinical outcomes are shown in Table 3 . Guidewire crossing was achieved in 44% with antegrade wire escalation, 21% with antegrade dissection reentry, and 35% with the retrograde approach. Bilateral injections were used in 75% and most cases were performed via femoral access (79% left femoral access and 52% right femoral access). Intravascular ultrasound was used more frequently in balloon undilatable lesions (65 vs. 42%, P < 0.003). The overall prevalence of balloon uncrossable lesions was 11.6% (n 5 49), of which 47% (n 5 23) were also balloon undilatable as compared with 8% among balloon crossable lesions (P < 0.001). Conversely, 44% (n 5 23) of balloon undilatable lesions were also balloon uncrossable.
Several techniques were used for lesion preparation, such as highpressure balloon inflations (64%), rotational atherectomy (RA) (31%), laser (21%), cutting balloon (15%), and AngioSculpt (Spectranetics, Fremont, CA) (14%) ( Table 4) . Two or more techniques were used in 48% of the undilatable lesions with higher overall technical (100 vs. 85%, P 5 0.112) and procedural (96 vs. 85%, P 5 0.350) success, and lower major complication rate (0 vs. 15%, P 5 0.112) as compared with cases in which only one technique was used.
| Procedural outcomes
The overall technical and procedural success rates were 98 and 95%, respectively and were lower in balloon undilatable lesions: technical success: 92 vs. 98%, (P 5 0.024); procedural success: 88 vs. 96% (P 5 0.034) ( Table 3 Procedural complications are presented in Table 5 . Balloon undilatable lesions were associated with higher incidence of in hospital MACE (8 vs. 2%, P 5 0.008), due to higher incidence of coronary perforations, including perforations causing tamponade and requiring pericardiocentesis (5.8 vs. 0.3%, P 5 0.007). Perforations were most commonly treated with prolonged balloon inflation (67% of all cases of perforations), anticoagulation reversal (33%), covered stent implantation (33%), emergency surgical evacuation (17%), and pericardiocentesis (17%).
| D I SCUSSION
To the best of our knowledge, this is the first study describing the prevalence and outcomes of balloon undilatable CTOs, The main findings were that balloon undilatable CTOs: (1) are common (12% of all CTOs); (2) often require use of aggressive vessel preparation techniques; and (3) are associated with lower technical and procedural success and higher in-hospital complication rates.
Balloon undilatable CTOs are lesions that fail to expand despite multiple balloon inflations after successful guidewire crossing, and balloon advancement within the target lesion. Stenting such lesions should be avoided until after adequate dilation has been achieved to prevent stent underexpansion, which in turn may predispose to in-stent restenosis and stent thrombosis [10, 11, 16] . As anticipated, balloon undilatable lesions were more likely to also be balloon uncrossable (in 44%), and to have longer length and heavy calcification.
The frequency of balloon undilatable lesions was high in our cohort, likely in part due to treatment of increasingly complex CTOs over time, such as lesions with severe calcification. Fernandez et al. Another option is to use an AngioSculpt (Spectranetics, Fremont, CA), or a cutting balloon [24] to create controlled incisions in the vessel wall that may assist with vessel expansion. However, these devices may be challenging to deliver to the lesion due to lack of flexibility caused by the wires or cutting blades and can be facilitated by using strong guide catheter support, for example by use of one or more guide catheter extensions (mother-daughter-granddaughter technique [25] ) or by using side branch anchoring [24, 26, 27] . The AngioSculpt, and the cutting balloon were utilized in 10 and 9%, respectively of our cases.
Additional strategies for expanding balloon undilatable lesions include laser (used in 13% in our cohort), or atherectomy (RA was used in 19% and orbital atherectomy in 4% of lesions in our study) [17, 28, 29] . Laser is easy to use and can be advanced over any standard 0.014 inch guidewire, whereas both orbital and rotational atherectomy require use of a specialized, thinner guidewire. Laser can be used even in previously stented lesions, whereas rotational or orbital atherectomy are avoided in this setting. In "balloon undilatable" lesions due to instent restenosis, laser can be activated with simultaneous contrast injection to modify the calcified plaque [30] . The LEONARDO study 18 (35) 84 (24) First crossing strategy 0.084 AWE, n (%)
36 (71) 293 (83) ADR, n (%) 4 (7) 23 (7) Retrograde, n (%)
11 (22) 39 (11) IVUS use overall 31 (65) 155 (42) 0.003 Proximal cap identification, n (%) 2 (7) 11 (7) 1.000 Guide wiring, n (%)
8 (26) 31 (20) 0.474 Stent sizing., n (%)
10 (32) 88 (57) 0.001 Guide reverse CART reentry, n (%)
1 (3) 3 (2) 0.521 Stent optimization, n (%)
22 (71) Laser atherectomy, n (%) 11 (21) 11 (100) 10 (91) 0 (0) 3 (14) RA, n (%) 16 (31) 14 (88) 14 (88) 1 (6) 2 (13) Orbital atherectomy, n (%) 3 (6) 3 (100) 3 (100) 0 (0) 0 (0)
Other, n (%) 4 (8) 
